gout-therapeutics-market
                     Gout Therapeutics Market
Set to Exceed $6,304.8 Million By 2026 | CAGR 14.8%
“Gout Therapeutics Market Share, Size, Trends, Industry 
Analysis Report, By Drug Class (Non-steroidal Anti-
Inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, 
Urate Lowering Agents) Disease Condition (Acute, Chronic); 
By Regions, Segments & Forecast, 2020 - 2026”
Gout Therapeutics Market Estimate & Forecast to 2026
The global gout therapeutics market size is expected to reach USD 6,304.8 million by 2026 
according to a new study by Polaris Market Research.
The incidence and prevalence of gout has increased over two-fold in past 20 years. This 
growth combined with increasing occurrence of comorbid conditions and cardiovascular risk 
factors represents a significant public health challenge. Globally, the developed countries 
tend to have a higher burden of gout compared to the developing countries, and also have 
increasing prevalence of this disease. There are various factors including genetic history, 
and ethnicity that could lead to occurrence of gout. Also, socioeconomic and dietary factors, 
as well as comorbidities and medications that can influence uric acid levels and facilitate 
MSU crystal formation, are also important in determining the risk of developing clinically 
evident gout.
Increasing geriatric population, and growing prevalence of this condition associated with this 
growing elderly population are the primary factors driving the growth of the industry. 
According to a study published in the Modern Medicine, elder population are more prone to 
develop tophi and the prevalence of metabolic syndrome among the elder population with 
gout was 62%. Currently, the geriatric population is growing at an extraordinary rate. 
According to the data published by the United Nations in 2012, global geriatric population 
was nearly 809.4 million inC op2yr0igh1t ©1 P olarins Mdar keits R esaeanrcthi &c Ciopnsaultineg dLL P t2o01 8.g Alrl Roigwhts  Rmeseorverde than double and reach 2
over 2,000 million by 2050.
Gout Therapeutics Market Scope
By Drug Class By Disease Condition By Region
•Non-steroidal Anti-Inflammatory Drugs • Acute •North America (U.S., Canada)
(NSAIDs) • Chronic •Europe (Germany, UK, France, Italy, Spain)
•Corticosteroids •Asia Pacific (China, India, Japan, South Korea)
•Colchicine •Latin America (Brazil, Mexico, Colombia)
•Urate Lowering Agents •MEA (Saudi Arabia, South Africa, Israel, UAE)
          Request for sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
Gout Therapeutics Market Estimate & Forecast to 2026
Furthermore, Europe also has a significant share in the global industry. Various international 
companies have been launching new products in the European market. For instance, in 
August 2018, Grünenthal received European approval for Duzallo (lesinurad/allopurinol) and 
extended its gout portfolio. However, Asia-Pacific is projected to witness a fastest growth 
during the forecast period. This highest growth is mainly anticipated due to the presence of 
several high economically growing countries such as India, China, South Korea, and other 
South Asian countries. Increasing number of people linked with smoking and alcohol 
consumption, growing population, increasing need for effective therapies, and growing 
expansion of local and international players in this regional segment are also fueling the 
growth of gout therapeutics market in this region.
 Access Research Report On Gout Therapeutics Market
The key players in the industry include AstraZeneca, Horizon Pharma Plc, Takeda 
Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin 
Pharma Limited, Regeneron Pharmaceuticals, Inc, Ironwood Pharmaceuticals, Inc., JW 
Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group among others.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
Gout Therapeutics Market Size
Speak To Analyst 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Gout Therapeutics Market Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: http://polarismarketresearch.blogspot.com/ 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980